Leveraging Project ECHO for Improved Cervical Cancer Screening in Ethiopia
- Sponsor
- Albert Einstein College of Medicine
- Study ID
- NCT07678047
- Status
- Enrolling By Invitation
Conditions
- Cervical Carcinoma
- Human Papilloma Virus (HPV)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- TICHILALECH ECHO — BEHAVIORALTICHILALECH ECHO, the study intervention, is a provider training and peer-mentoring intervention that will be delivered through 1-hour virtual sessions with multidisciplinary teams of cervical cancer screening stakeholders, organized in modules with sessions delivered at a regular cadence across three years. Project ECHO sessions will address challenges to improving the screen-triage-treat cascade of care identified by a situational assessment, however, the study will not directly intervene on the screen-triage-treat cascade. Participants will present case studies from their practice for input and guidance from other participants.
Study Details
Project TICHILALECH ("she can" in Amharic), a five-year, implementation science study, is focused on improving cervical cancer screening, triage, and treatment and integration with human immunodeficiency virus (HIV) care at five Ethiopian hospitals, with a focus on human papillomavirus (HPV) self-collection as the recommended screening strategy for people living with HIV (PLHIV). To improve implementation of screening and treatment, Project ECHO (Extension for Community Healthcare Outcomes), a peer-based, virtual, knowledge sharing model, will be used to convene healthcare providers and stakeholders over a period of approximately three years (2026-2029). A customized curriculum is developed featuring didactic lectures, case-based presentations, and experience sharing for peer-mentoring. A pre/post study design will measure changes in delivery of clinical services, such as the proportion of HPV-positive patients that are appropriately triaged and treated, before and after each hospital's participation in the TICHILALECH ECHO intervention.
Key Dates
- First listed
- Jul 1, 2026
- Start date
- Jun 24, 2026
- Status verified
- Jun 2026
- Primary completion
- Jul 31, 2029
- Completion
- Jul 31, 2029
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- PREVENTION
Arms
- Experimental: Participation in TICHILALECH ECHOHealthcare providers and relevant stakeholders participate in TICHILALECH ECHO, a peer-to-peer virtual learning modality.
Primary Outcome Measure
Triage Examination Percentage Among Screen-Positive People Living with HIV (PLHIV) [ Time Frame: Baseline: 12 months prior to TICHILALECH ECHO study intervention; Post: Up to 12 months following TICHILALECH ECHO study intervention ]
Find similar trials
Related Studies
- Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological CancersPHASE2 · Recruiting · Emory University · Atlanta, Georgia
- The Ohio State University (OSU) SCREEN Community ProgramRecruiting · Ohio State University Comprehensive Cancer Center · Columbus, Ohio
- HPV Vaccine, Imiquimod, and Metformin Combination TrialPHASE2 · Recruiting · Baylor College of Medicine · Houston, Texas
- Unidos Contra el VPHRecruiting · University of Texas at Austin · El Paso, Texas